Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.
Haidinger M, Werzowa J, Hecking M, Antlanger M, Stemer G, Pleiner J, Kopecky C, Kovarik JJ, Döller D, Pacini G, Säemann MD. Haidinger M, et al. Among authors: kopecky c. Am J Transplant. 2014 Jan;14(1):115-23. doi: 10.1111/ajt.12518. Epub 2013 Nov 26. Am J Transplant. 2014. PMID: 24279801 Free article. Clinical Trial.
A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.
Werzowa JM, Säemann MD, Mohl A, Bergmann M, Kaltenecker CC, Brozek W, Thomas A, Haidinger M, Antlanger M, Kovarik JJ, Kopecky C, Song PXK, Budde K, Pascual J, Hecking M. Werzowa JM, et al. Among authors: kopecky c. PLoS One. 2018 Mar 8;13(3):e0193569. doi: 10.1371/journal.pone.0193569. eCollection 2018. PLoS One. 2018. PMID: 29518094 Free PMC article. Clinical Trial.
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety.
Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, Pacini G, Wrba T, Antlanger M, Schmaldienst S, Werzowa J, Säemann MD, Hecking M. Schwaiger E, et al. Among authors: kopecky c. Am J Transplant. 2019 Mar;19(3):907-919. doi: 10.1111/ajt.15223. Epub 2019 Jan 25. Am J Transplant. 2019. PMID: 30585690 Free PMC article.
Combined sodium glucose co-transporter-2 inhibitor and angiotensin-converting enzyme inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trial.
Antlanger M, Domenig O, Kaltenecker CC, Kovarik JJ, Rathkolb V, Müller MM, Schwaiger E, Hecking M, Poglitsch M, Säemann MD, Kopecky C. Antlanger M, et al. Among authors: kopecky c. Diabetes Obes Metab. 2022 May;24(5):816-826. doi: 10.1111/dom.14639. Epub 2022 Jan 24. Diabetes Obes Metab. 2022. PMID: 34984822 Free PMC article. Clinical Trial.
Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.
Haidinger M, Werzowa J, Kain R, Antlanger M, Hecking M, Pfaffenberger S, Mascherbauer J, Gremmel T, Gilbertson JA, Rowczenio D, Weichhart T, Kopecky C, Hörl WH, Hawkins PN, Säemann MD. Haidinger M, et al. Among authors: kopecky c. Amyloid. 2013 Jun;20(2):72-9. doi: 10.3109/13506129.2013.781998. Epub 2013 Apr 3. Amyloid. 2013. PMID: 23551149
Restoration of renal function does not correct impairment of uremic HDL properties.
Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD. Kopecky C, et al. J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28. J Am Soc Nephrol. 2015. PMID: 25071090 Free PMC article.
Molecular regulation of the renin-angiotensin system in haemodialysis patients.
Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD. Kovarik JJ, et al. Among authors: kopecky c. Nephrol Dial Transplant. 2015 Jan;30(1):115-23. doi: 10.1093/ndt/gfu265. Epub 2014 Aug 8. Nephrol Dial Transplant. 2015. PMID: 25107336 Clinical Trial.
Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.
Kovarik JJ, Kopecky C, Antlanger M, Domenig O, Kaltenecker CC, Werzowa J, Hecking M, Mahr S, Grömmer M, Wallner C, Aumayr K, Kain R, Zuckermann A, Poglitsch M, Säemann MD. Kovarik JJ, et al. Among authors: kopecky c. J Heart Lung Transplant. 2017 Mar;36(3):355-365. doi: 10.1016/j.healun.2016.08.022. Epub 2016 Sep 13. J Heart Lung Transplant. 2017. PMID: 27773450
Molecular remodeling of the renin-angiotensin system after kidney transplantation.
Antlanger M, Domenig O, Kovarik JJ, Kaltenecker CC, Kopecky C, Poglitsch M, Säemann MD. Antlanger M, et al. Among authors: kopecky c. J Renin Angiotensin Aldosterone Syst. 2017 Apr-Jun;18(2):1470320317705232. doi: 10.1177/1470320317705232. J Renin Angiotensin Aldosterone Syst. 2017. PMID: 28490223 Free PMC article.
58 results